S&P DJI Announces September 2025 Quarterly Rebalance
Filed with ASX · · 7 pages · English
Story so far
Earlier from PolyNovo
- U.S. Medicare Reimbursement Proposal
- FY25 Results Presentation
- Appendix 4E and FY25 Financial Statements
- FY25 Trading Result (unaudited)
- BTM delivers positive First in Man results in Cell Therapies
Later from PolyNovo
- Pause in Trading
- Trading Halt
- Chronic diabetic-related wound study results
- CEO appointment - Mr. Bruce Peatey
- Trading Results Q1 FY26 (unaudited)
Follow PolyNovo into a list and get an email when it puts out news.
Follow PolyNovo